ALNYLAM PHARMACEUTICALS, INC. - FORM 10-K - EX-21.1 - February 11, 2021

Attached files

file filename
10-K - 10-K - ALNYLAM PHARMACEUTICALS, INC.alny-20201231.htm
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC.alny2020q4exhibit-322.htm
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC.alny2020q4exhibit-321.htm
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC.alny2020q4exhibit-312.htm
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC.alny2020q4exhibit-311.htm
EX-23.1 - EX-23.1 - ALNYLAM PHARMACEUTICALS, INC.alny2020q4exhibit-231.htm
EX-10.20 - EX-10.20 - ALNYLAM PHARMACEUTICALS, INC.alny2020q4exhibit-1020.htm
EX-10.12 - EX-10.12 - ALNYLAM PHARMACEUTICALS, INC.alny2020q4exhibit-1012.htm

EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
 
Name Ownership Percentage Jurisdiction of Organization
Alnylam U.S., Inc. 100% Delaware
Alnylam Securities Corporation100%Massachusetts
Sirna Therapeutics, Inc.100%Delaware
Alnylam Austria GmbH100%Austria
Alnylam Belgium BVBA100%Belgium
Alnylam Brasil Farmaceutica Ltda99%Brazil
Alnylam (Bermuda) Ltd. 100% Bermuda
Alnylam Canada ULC100%Canada
Alnylam France SAS 100% France
Alnylam Europe AG100%Germany
Alnylam Germany GmbH100%Germany
Alnylam Italy Srl 100% Italy
Alnylam Japan KK100%Japan
Alnylam Netherlands BV100%Netherlands
Alnylam Pharmaceuticals Spain SL100%Spain
Alnylam Sweden AB100%Sweden
Alnylam Switzerland GmbH100%Switzerland
Alnylam Taiwan Co., Ltd.100%Taiwan
ALNYPT Unipessoal Lda100%Portugal
Alnylam UK Limited100%United Kingdom
Alnylam Czech s.r.o.100%Czech Republic
Alnylam Argentina Srl100%Argentina


ALNYLAM PHARMACEUTICALS, INC. Reports